ABOUT
Company Profile
Founded in 2019, Calgent Biotechnology develops innovative oncology and immunology therapies that address unmet medical needs.
Our integrated R&D platform covering translational research, pharmacology, formulation, and clinical development accelerates drug discovery and development.
We combine proprietary programs with strategic in-licensing to build a robust pipeline and foster collaborative partnerships.
Guided by our core values of innovation, precision, and efficiency, we are committed to delivering transformative treatments with a long-term focus on age-related diseases and healthy aging.
Management Team
Chair of Board
Dr. Yun Yen MD, PhD
Education
- Taipei Med University (MD)
- Thomas Jefferson University (PhD)
- Yale University School of Medicine (Hem Onc Fellow)
Career Experience
- Over 40 years in translational medicine, oncology, and clinical practice
- Inventor on 80+ patents and author of over 400 scientific publications
- Held senior leadership roles including President of Taipei Medical University and Deputy Director at City of Hope National Medical Center
- Adjunct/Affiliate appointments at Caltech, Case Western Reserve University, Taipei Medical University, and Academia Sinica
- Fellow of the U.S. National Academy of Inventors
- Chair, Biomedical Division, Advanced Technology Advisory Committee, Industrial Technology Research Institute
- Member, Biotechnology Industry Strategy Advisory Committee
- Board Member, National Health Research Institutes and Tzu Chi Medical Foundation
CEO
Hui Wen Huang
Education
- E.M.B.A., Business Administration, National Taiwan University
Career Experience
- Over 25 years of executive leadership in the biomedical industry, spanning drug development, medical devices, healthcare management, and CRO operations
- Extensive expertise in regulatory strategy, IP, market analysis, and commercial valuation
- Former Director of Business Development at Taipei Medical University and General Manager of affiliated healthcare and pharmaceutical companies
- Senior leadership roles in CRO and pharmaceutical marketing
- Advisor to government agencies and national biotech parks on policy and strategic review
Independent Director at Lightek Corporation
Chief Financial Officer of Finance Dept.
Sherry Dai
Education
- M.S., Business Administration, National Taipei University
Career Experience
- Over 25 years of financial management experience, including 20+ years in high-tech industries such as semiconductors, solar energy, and medical devices
- Former Chief Financial Officer and corporate spokesperson for publicly listed companies, successfully leading IPOs and OTC market entries
- Skilled in financial systems, internal controls, investor relations, and HR administration
- Certified executive for publicly listed companies
Director of Business Development Dept.
Jenny Jang
Education
- M.S., Nutrition, Pennsylvania State University, USA
- M.S., Institute of Microbiology & Biochemistry, National Taiwan University
- B.S., Biochemical Science and Technology, National Taiwan University
Career Experience
- Over 20 years of business development experience in the biomedical sector
- Former Director of Business Development at Tanvex BioPharm, Head of Commercialization at Development Center for Biotechnology
- Held senior management roles at pharma and biotech companies including Gold NanoTech, Global Investment Holdings, NatureWise, and Orient EuroPharma
Director of Clinical Research & Operation Dept.
Jing Yi Lee
Education
- Ph.D. in PharmacologySchool, National Yang-Ming University
Career Experience
- Over 11 years of experience in small molecule drug development for metabolic, dermatological, rare diseases, and oncology indications
- Experienced in clinical and non-clinical research, CRO management, and project oversight
- Led design and execution of Phase I/II clinical trials and key toxicology study audits
- Former Scientific Expert at Paraxel International and Associate Director of Medical Research at TWi Biotechnology
Director of CMC & Formulation Dept.
Yu Tsai Yang
Education
- Ph.D., School of Dentistry-Master and PhD Program, Taipei Medical University
Career Experience
- Over 16 years hands-on experience in formulation development, drug delivery technologies, and process development
- Specializes in oral delivery platforms for protein therapeutics; holder of multiple international patents
- Former Director of Drug Development at Innopharmax
Director of Translational Research Dept.
MingZi Zhang
Education
- Ph.D., Chemical Biology, Rockefeller University
- B.Sc., Bacteriology, University of Wisconsin-Madison
Career Experience
- Over 10 years of interdisciplinary research experience bridging chemistry and biology in biomedical science
- Associate Investigator at Institute of Molecular and Genomic Medicine, National Health Research Institutes
- Former Agency for Science Technology and Research (A*STAR) Scientist
Director of Administration Management Dept.
Alice Yang
Education
- Ph.D. Candidate, School of Business, Chang Gung University
- M.S., Professional Master’s Program of Law in Business Administration, National Taiwan University
- M.S., EMBA, School of Business, Chang Gung University
- M.S., the Medical Institute, Kaohsiung Medical University
Career Experience
- Over 16 years of experience in regulatory affairs, project management, market strategy, and legal practice in the biomedical sector
- Former roles at Lotus Pharmaceutical, Bora Pharmaceuticals Ophthalmic, and the Taiwan FDA (TFDA)
Scientific Advisory Board
Robert B. Diasio, M.D.
Mayo Clinic Cancer Center
James Mulé, PhD
Moffitt Cancer Center
Jacqueline Whang-Peng, M.D., Ph.D.
Academician, Academia Sinica, ROC
Robert B. Diasio, M.D.
Mayo Clinic Cancer Center
James Mulé, PhD
Moffitt Cancer Center
Jacqueline Whang-Peng, M.D., Ph.D.
Academician, Academia Sinica, ROC